Bank of America
XBIT icon

Bank of America’s XBiotech XBIT Stock Holding History

Bank of America’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,600
Closed -$43K – 7201
2017
Q1 		$43K Buy
+2,600
New +$34K ﹤0.01% 5997

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America's XBIT Position: Q1 2026 in Review

Bank of America increased its XBiotech (XBIT) stake by 2.2% in Q1 2026, buying an estimated $1.92K and bringing the position to 36,689 shares worth $86.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5546.

Bank of America first reported a position in XBIT in Q2 2015 and has held it in 43 quarters since. The position peaked at $2.94M in Q1 2020. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Bank of America held 36,689 shares of XBiotech worth $86.2K as of Q1 2026.
  • Bank of America bought 794 XBiotech shares in Q1 2026, an estimated $1.92K.
  • XBiotech made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5546 holding.
  • Bank of America first reported a position in XBiotech in Q2 2015 and has held it in 43 quarters since.
  • Bank of America's XBiotech position peaked at $2.94M in Q1 2020.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.